Alissa Clear, PhD is a manager at Clarion. Her project experience encompasses scientific and commercial strategy across a range of therapeutic areas, with a focus on oncology and rare disease. Alissa’s projects have included competitive intelligence and pipeline strategy, target & indication prioritizations, and go-to-market, LCM, and brand/franchise strategy. Her functional expertise includes market research, opportunity assessments, due diligence, and strategy development.
Prior to joining Clarion, Alissa worked in life sciences consulting in the San Francisco Bay Area. Alissa received her PhD in Molecular Biology and Genetics from the Irell & Manella Graduate School of City of Hope, where her research aimed to better understand DNA repair mechanisms underlying cancer susceptibility and to identify protein regions for future drug development. Her postdoctoral fellowship at the Public Health Research Institute of Rutgers/NJMS focused on the genetic underpinnings of antifungal drug resistance.
Alissa completed her BS in Biology, with a minor in French, at Purdue University.